Kai Strohbecke
Analyst · Bank of America. Your line is now open
Thank you, Mark, and hello everyone. I will discuss the drivers and details of last of performance and then provide guidance for the current quarter total shipments for the third quarter. Were 605 megawatts consistent with our guidance range of 580 megawatts to 620 megawatts. This represents a 16% sequential increase attributable large lead to our first full quarter of US utility scale shipments from our North American MoCo. That is still ramping up its capacity. DG volumes were also sequentially led by increased volumes of Maxeon six from recently converted capacity in factory revenues for the third quarter were $275 million, also consistent with our guidance range and representing a 16% sequential increase. DG ASPs were up in many geographies due to a combination of price increases and a higher mix of beyond the panel revenue. However, total blended as P was diluted by a higher mix of utility scale volume as well as some opportunistic sell sales. Non-GAAP gross income in the third quarter was negative 16 million in line with our guidance of negative $10 million to $20 million and an improvement of $8 million from our second quarter results, which we have earlier identified as the trust in our multi-year transformation. The sequential improvement reflects the higher mix of our flagship max on six panels, a higher mix of beyond the panel products and geographic optimization strategies. In the third quarter, cost of goods sold includes $1 million of out of market poly silicon charges related to our legacy supply contract. This figure is now significantly smaller than historical levels as policy comprises in the market have come very close to our fixed contract price. The year over year impact of supply chain cost inflation on our cost of goods sold was $17 million. This was more than offset upset by $26 million of as cost increases as previously projected supply chain cost increases have been slowing down or even started reversing in some cases while we continued to increase our prices in DG markets based on the strong demand. As a result, our DG business was meaningfully growth margin positive. In the third quarter, our growth loss is attributable to our new US utility scale business where we are still seeing underutilization in our partially rent facilities and other startup expenses that impact cogs as well as below market ASPs from our first half 2021 bookings manufacturing volume of our Malaysian performance line sales rep and North American increased materially during the quarter, but were both still well below the target capacity that we plan to reach in 2023. This contributed the majority of the overall Maxeon level underutilization charges totaling $10 million in the quarter. In the third quarter, we also recognized $16.8 million in additional lower of cost on market write downs on performance line inventories. Non-GAAP operating expenses were 35 million in the third quarter. In line with our guidance adjusted EBITDA in the third quarter was negative 35 million, which is improved from the second quarter and within our guidance range gap net loss came in at $45 million compared to 88 million in the previous quarter. Moving onto the balance sheet, we closed the third quarter with cash, cash equivalence, cash and short term investments of $314 million compared to $180 million at the end of the second quarter. The sequential increase was driven by our 207 million convertible bond issuance, partially offset upset by CapEx spending, operating losses and higher inventories as we rent deliveries into our end markets. For further growth. DIO increased sequentially from 89 days to 91 days. Capital expenditures in the third quarter were $16 million, which was below our guidance range of $21 million to $25 million. As we maintain payment discipline while continuing to spend our CapEx on nexon six and performance line capacity for the US overall, we are pleased to have executed in the third quarter. In line with our plan improved our financial performance from our margin drop in the second quarter and position the company to deliver positive cross margins in the fourth quarter. This performance was a result of previous investments in DG that are now starting to show tangible results and still reflect the burden of a ramping US utility scale business. With legacy ASPs, we expect to see sequentially improving quarterly performance over the course of the next year leading up to the achievement of our long-term financial models with gross margins of at least 15% before the end of 2023. We expect to achieve this financial turnaround based partly on the already contracted utility scale prices in the second half of 2023, utility scale cost reduction as our factories become fully ramped, strong DG pricing in the US and EU and an increased mix of beyond the panel revenue. With these points in mind, I now turn to our expectations for the fourth quarter of 2022, we project fourth quarter shipments of between 680 megawatts and 720 megawatts. The midpoint of this guidance represents the 16% sequential volume growth. The largest growth driver will be US utility scale volumes, which we expect to continue in 2023 until our facilities reach for rank. We project revenue of 290 to 330 million. The midpoint of these numbers end of our shipment guidance imply a slight A S P decrease sequentially, which is attributable to a higher mix of utility scale shipment. DG ASPs are expected to increase slightly on higher panel prices in the greater mix of beyond the panel revenue. Non-GAAP gross profit is expected to be in the range of breakeven to 10 million. The largest contributor in expected sequential improvement is unit cost reduction on performance line as we ran. Capacity included in gross margin guidance is a $1 million charge for out of market poly silicon. This contract is expiring soon, but the P&L impact will continue into early 2023 as we sell products that incorporate this raw material non-GAAP. Operating expenses in the fourth quarter are projected to be 36 million plus or minus 2 million slightly up from third quarter levels. However, as a percentage of revenue, our OpEx is expected to become more efficient both in the fourth quarter and into 2023. As just one example, our sales of power electronics storage and EV chargers will be executed largely by the same DG sales and logistics teams that handle our panel sales. Non-GAAP EBITDA is projected to be in the range of negative $17 million to negative $27 million, demonstrating sequential improvement in line with gross income capital expenditures are projected to be in the range of $16 million to $20 million. The majority of this spend is for our performance line ramp in 2023. We will continue to spend CapEx for completing the ramp of our performance line capacity for the US market. We intend to finance this CapEx from our reasons $207 million convert issuance. As Mark discussed, we are working on a plan for Mexon seven capacity expansion, and because of that, our previous CapEx indication for retrofitting Mexon three production lines is no longer relevant. Furthermore, we anticipate that spending for our proposed three gigawatt facility in the US may commence in 2023. Our financing plan remains contingent on a successful application with the US Department of Energy Loan guarantee program for a majority of the CapEx for the remaining funds required. We will consider options including customer co-investment, strategic partnerships, company, ATA generation, and the capital markets in interest in this project remains very high from a variety of different stakeholders. We will finalize a financing strategy over the next several months that we believe will be in the best interest of max shareholders. With that, I'll turn the call back to Mark to summarize before we go to Q&A,